|
1
|
Morales-Sánchez A and Fuentes-Pananá EM:
Human viruses and cancer. Viruses. 6:4047–4079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Xu X, Yang Z, Chen Q, Yu L, Liang S, Lü H
and Qiu Z: Comparison of clinical characteristics of chronic cough
due to non-acid and acid gastroesophageal reflux. Clin Respir J.
9:196–202. 2015. View Article : Google Scholar
|
|
3
|
Ok CY, Papathomas TG, Medeiros LJ and
Young KH: EBV-positive diffuse large B-cell lymphoma of the
elderly. Blood. 122:328–340. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Young LS and Rickinson AB: Epstein-Barr
virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tokunaga M, Land CE, Uemura Y, Tokudome T,
Tanaka S and Sato E: Epstein-Barr virus in gastric carcinoma. Am J
Pathol. 143:1250–1254. 1993.PubMed/NCBI
|
|
6
|
Takada K: Epstein-Barr virus and gastric
carcinoma. Mol Pathol. 53:255–261. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Pfitzner AJ, Tsai EC, Strominger JL and
Speck SH: Isolation and characterization of cDNA clones
corresponding to transcripts from the Bam HI H and F regions of the
Epstein-Barr virus genome. J Virol. 61:2902–2909. 1987.PubMed/NCBI
|
|
8
|
Kelly GL, Long HM, Stylianou J, Thomas WA,
Leese A, Bell AI, Bornkamm GW, Mautner J, Rickinson AB and Rowe M:
An Epstein-Barr virus anti-apoptotic protein constitutively
expressed in transformed cells and implicated in burkitt
lymphomagenesis: The Wp/BHRF1 link. PLoS Pathog. 5:e10003412009.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Taub R, Kirsch I, Morton C, Lenoir G, Swan
D, Tronick S, Aaronson S and Leder P: Translocation of the c-myc
gene into the immunoglobulin heavy chain locus in human Burkitt
lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci USA.
79:7837–7841. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Adams JM, Harris AW, Pinkert CA, Corcoran
LM, Alexander WS, Cory S, Palmiter RD and Brinster RL: The c-myc
oncogene driven by immunoglobulin enhancers induces lymphoid
malignancy in transgenic mice. Nature. 318:533–538. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Magrath I: The pathogenesis of Burkitt's
lymphoma. Adv Cancer Res. 55:133–270. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Strasser A, Harris AW, Bath ML and Cory S:
Novel primitive lymphoid tumours induced in transgenic mice by
cooperation between myc and bcl-2. Nature. 348:331–333. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beverly LJ and Varmus HE: MYC-induced
myeloid leukemo-genesis is accelerated by all six members of the
antiapoptotic BCL family. Oncogene. 28:1274–1279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee KM, Danuser R, Stein JV, Graham D,
Nibbs RJ and Graham GJ: The chemokine receptors ACKR2 and CCR2
reciprocally regulate lymphatic vessel density. EMBO J.
33:2564–2580. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hlatky L, Hahnfeldt P and Folkman J:
Clinical application of antiangiogenic therapy: Microvessel
density, what it does and doesn't tell us. J Natl Cancer Inst.
94:883–893. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yates JL, Warren N and Sugden B: Stable
replication of plasmids derived from Epstein-Barr virus in various
mammalian cells. Nature. 313:812–815. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gires O, Zimber-Strobl U, Gonnella R,
Ueffing M, Marschall G, Zeidler R, Pich D and Hammerschmidt W:
Latent membrane protein 1 of Epstein-Barr virus mimics a
constitutively active receptor molecule. EMBO J. 16:6131–6140.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dawson CW, Port RJ and Young LS: The role
of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the
pathogenesis of nasopharyngeal carcinoma (NPC). Semin Cancer Biol.
22:144–153. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Burke AP, Yen TS, Shekitka KM and Sobin
LH: Lymphoepithelial carcinoma of the stomach with Epstein-Barr
virus demonstrated by polymerase chain reaction. Mod Pathol.
3:377–380. 1990.PubMed/NCBI
|
|
20
|
Shibata D and Weiss LM: Epstein-Barr
virus-associated gastric adenocarcinoma. Am J Pathol. 140:769–774.
1992.PubMed/NCBI
|
|
21
|
Shannon-Lowe C and Rowe M: Epstein Barr
virus entry; kissing and conjugation. Curr Opin Virol. 4:78–84.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tsao SW, Tsang CM, Pang PS, Zhang G, Chen
H and Lo KW: The biology of EBV infection in human epithelial
cells. Semin Cancer Biol. 22:137–143. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Woellmer A and Hammerschmidt W:
Epstein-Barr virus and host cell methylation: Regulation of
latency, replication and virus reactivation. Curr Opin Virol.
3:260–265. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chen JN, He D, Tang F and Shao CK:
Epstein-Barr virus-associated gastric carcinoma: A newly defined
entity. J Clin Gastroenterol. 46:262–271. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Frappier L: Role of EBNA1 in NPC
tumourigenesis. Semin Cancer Biol. 22:154–161. 2012. View Article : Google Scholar
|
|
26
|
Robertson KD, Manns A, Swinnen LJ, Zong
JC, Gulley ML and Ambinder RF: CpG methylation of the major
Epstein-Barr virus latency promoter in Burkitt's lymphoma and
Hodgkin's disease. Blood. 88:3129–3136. 1996.PubMed/NCBI
|
|
27
|
Lauria R, Perrone F, Carlomagno C, De
Laurentiis M, Morabito A, Gallo C, Varriale E, Pettinato G, Panico
L, Petrella G, et al: The prognostic value of lymphatic and blood
vessel invasion in operable breast cancer. Cancer. 76:1772–1778.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Kyzas PA, Geleff S, Batistatou A, Agnantis
NJ and Stefanou D: Evidence for lymphangiogenesis and its
prognostic implications in head and neck squamous cell carcinoma. J
Pathol. 206:170–177. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chua B, Ung O, Taylor R and Boyages J:
Frequency and predictors of axillary lymph node metastases in
invasive breast cancer. ANZ J Surg. 71:723–728. 2001. View Article : Google Scholar
|
|
30
|
Cunnick GH, Jiang WG, Gomez KF and Mansel
RE: Lymphangiogenesis and breast cancer metastasis. Histol
Histopathol. 17:863–870. 2002.PubMed/NCBI
|
|
31
|
Skobe M, Hawighorst T, Jackson DG, Prevo
R, Janes L, Velasco P, Riccardi L, Alitalo K, Claffey K and Detmar
M: Induction of tumor lymphangiogenesis by VEGF-C promotes breast
cancer metastasis. Nat Med. 7:192–198. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
He Y, Karpanen T and Alitalo K: Role of
lymphangiogenic factors in tumor metastasis. Biochim Biophys Acta.
1654:3–12. 2004.PubMed/NCBI
|
|
33
|
Salven P, Mustjoki S, Alitalo R, Alitalo K
and Rafii S: VEGFR-3 and CD133 identify a population of CD34+
lymphatic/vascular endothelial precursor cells. Blood. 101:168–172.
2003. View Article : Google Scholar
|
|
34
|
Brink AA, Vervoort MB, Middeldorp JM,
Meijer CJ and van den Brule AJ: Nucleic acid sequence-based
amplification, a new method for analysis of spliced and unspliced
Epstein-Barr virus latent transcripts, and its comparison with
reverse transcriptase PCR. J Clin Microbiol. 36:3164–3169.
1998.PubMed/NCBI
|
|
35
|
Zheng H, Li LL, Hu DS, Deng XY and Cao Y:
Role of Epstein-Barr virus encoded latent membrane protein 1 in the
carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol.
4:185–196. 2007.PubMed/NCBI
|
|
36
|
zur Hausen A, Brink AA, Craanen ME,
Middeldorp JM, Meijer CJ and van den Brule AJ: Unique transcription
pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric
adeno-carcinomas: Expression of the transforming BARF1 gene. Cancer
Res. 60:2745–2748. 2000.PubMed/NCBI
|
|
37
|
Chang MS, Kim DH, Roh JK, Middeldorp JM,
Kim YS, Kim S, Han S, Kim CW, Lee BL, Kim WH and Woo JH:
Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric
carcinoma cells through regulation of NF-kB. J Virol.
87:10515–10523. 2013. View Article : Google Scholar : PubMed/NCBI
|
